Updates in endoscopic bariatric and metabolic therapies.
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The rising prevalence of obesity, and related morbidity and mortality, has necessitated the development of therapeutic weight loss strategies. Lifestyle modifications alone have only yielded modest benefit, and while bariatric surgery has shown significant short- and long-term results, only a minority of eligible patients end up receiving this treatment. Endoscopic bariatric and metabolic therapies (EBMTs) are a rapidly evolving field, which provides a less invasive middle ground treatment option for weight loss. Here we discuss the efficacy, as well as short- and long-term outcomes with restrictive, malabsorptive/metabolic and aspiration endoscopic techniques, and their effects on metabolic parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse effects include nausea/vomiting (20%) and abdominal pain (7%).118”
From Obesity Management in Adults: A Review (2023) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O’Brien, P. E., Hindle, A., Brennan, L., Skinner, S., Burton, P., Smith, A., Crosthwaite, G., & Brown, W. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3525-0 · Cited by 815 · cited 1×
“The EBMT procedures can largely be subdivided into restrictive, malabsorptive/metabolic and aspiration techniques depending on their target [8].”
BackgroundPeterli, R., Steinert, R. E., Woelnerhanssen, B., Peters, T., Christoffel-Courtin, C., Gass, M., Kern, B., von Fluee, M., & Beglinger, C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0622-3 · Cited by 529
Abu Dayyeh, B. K., Kumar, N., Edmundowicz, S. A., Jonnalagadda, S., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1964 · Cited by 469 · cited 3×
“In three randomized controlled trials (RCTs) comparing Orbera balloon placement to controls, % EBWL was 26.9% (95% CI, 15.6 – 38.2; p ≤ 0.01) [7].”
BackgroundMethodInfluentialAssociation of body mass index with health care expenditures in the united states by age and sex
Ward, Z. J., Bleich, S. N., Long, M. W., & Gortmaker, S. L. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247307 · Cited by 428 · cited 1×
“As such, obesity and its complications have been recognized as a public health crisis and concerted efforts targeting development of preventive and treatment strategies is ongoing [2,3].”
BackgroundAbu Dayyeh, B. K., Bazerbachi, F., Vargas, E. J., Sharaiha, R. Z., Thompson, C. C., Thaemert, B. C., Teixeira, A. F., Chapman, C. G., Kumbhari, V., Ujiki, M. B., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01280-6 · Cited by 338 · cited 1×
“All were successfully treated [25].”
Abu Dayyeh, B. K., Acosta, A., Camilleri, M., Mundi, M. S., Rajan, E., Topazian, M. D., & Gostout, C. J. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.030 · Cited by 305
Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis
Hedjoudje, A., Abu Dayyeh, B. K., Cheskin, L. J., Adam, A., Neto, M. G., Badurdeen, D., Morales, J. G., Sartoretto, A., Nava, G. L., Vargas, E., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.022 · Cited by 266 · cited 1×
“The pooled adverse event rate was 2.2% [23].”
BackgroundInfluentialShort-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients
Alqahtani, A., Al-Darwish, A., Mahmoud, A. E., Alqahtani, Y. A., & Elahmedi, M. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.12.012 · Cited by 207 · cited 1×
“These hormonal changes are thought to contribute to a higher weight loss observed with LSG compared to ESG, because even though ESG mimics LSG in terms of anatomic alterations it does not seem to reproduce the same hormonal changes [30,35,36].”
BackgroundThompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.500 · Cited by 201 · cited 2×
“Serious adverse effects are rare, including peritonitis and prepyloric ulceration or tube removal [50].”
Backgroundvan Baar, A. C. G., Holleman, F., Crenier, L., Haidry, R., Magee, C., Hopkins, D., Rodriguez Grunert, L., Galvao Neto, M., Vignolo, P., Hayee, B., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318349 · Cited by 201
Research works printed but not linked: 1
- Stahl J.M. Malhotra S. Obesity Surgery Indications and Contraindications StatPearls Publishing Treasure Island, FL, USA 2018 30020657
Cited by
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Nduma, B. N., Mofor, K. A., Tatang, J., Amougou, L., Nkeonye, S., Chineme, P., Ekhator, C., & Ambe, S. (2023) · Cureus · doi:10.7759/cureus.41466 · Cited by 12
“(2023) [17] Whereas the total body weight loss in the ESG group was documented to be lower than that in the LSG group, the rate of adverse events in the ESG group was established to be more promising.”
BackgroundFrom pathophysiology to novel approaches for obesity-associated hypertension
Kanbay, M., Yayci, E., Genc, C., Çöpür, S., Aktaş, Ö. Y., Sarafidis, P. A., Covic, A. C., Ortíz, A., & Laffin, L. J. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf218 · Cited by 12
“Endoscopic gastric plication, gastric aspiration, duodenal mucosal resurfacing, endoscopic anastomosis systems and endoscopic bypass liners are other potential endoscopic bariatric procedures with limited clinical experience [113 ].”
Abaalkhail, F. A., Sanai, F. M., Alswat, K., Alzanbagi, A., Al-Jedai, A. H., Alshehri, A., Alfadda, A. A., Alghamdi, H., Almadi, M. A., AlEissa, M., et al. (2025) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_199_25 · Cited by 12
A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications
Abuawwad, M., Tibude, A., Bansi, D. S., IDRIS, I. R., & Madhok, B. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15613 · Cited by 9
“4,9,48 Nduma et al. published a systematic review of 20 studies confirming a superior safety profile of ESG, including a lower risk of de-novo gastric oesophageal reflux disease (GORD), whereas SG resulted in a higher weight loss and a higher chance of remission of obesity-related comorbidities.”
BackgroundTripathi, S., Ray, A. K., Sinha, Y., Reid, A., & Noormohamed, S. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08358-7 · Cited by 7
Farooque, U., Qadri, S. H., da Silva, A. B. N., Malaj, A., Aparna, F., Murtaza, M., Ahsan, W., Warsi, A., Badurdeen, D., & Shaukat, A. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08310-9 · Cited by 5
“Endoscopic Sleeve Gastroplasty (ESG), considered one of the most effective endoscopic bariatric metabolic therapies (EBMTs), achieved a mean %TBWL of 15.1% at 6 months and sustained results of 16.5% and 17.2% at 12 and 18–24 months, respectively, with a %EWL of 57.7% [21].”
InfluentialKurmanskyi, A., Tkachuk, O. V., & Kebkalo, A. (2025) · Polish Journal of Surgery · doi:10.5604/01.3001.0055.2330 · Cited by 3
Fernandez, C. J., Jena, S., Lakshmi, V., & Pappachan, J. M. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i28.109468 · Cited by 4
Albon, E., Afentou, N., Dretzke, J., Hall, J., Ogwulu, C. O., Price, M. J., Clare, K., Singhal, R., Tahrani, A. A., Frew, E. J., et al. (2025) · Health Technology Assessment · doi:10.3310/pwkq2310 · Cited by 2
Endoluminal bariatric and metabolic therapies: state-of-the-art
Bakheet, N. G., Badurdeen, D., Sartoretto, A., & Kumbhari, V. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000967 · Cited by 2
“Duodenal Mucosal Resurfacing (DMR) is an endoscopic technique that targets the distal 10cm of duodenal mucosa after the major papilla [74].”
BackgroundMethodInfluentialUpdates in nonalcoholic fatty liver disease
Wungjiranirun, M., Wong, N., Jou, J. H., & Moylan, C. A. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000085 · Cited by 2
Korram, P., Sahu, P., & Satapathy, T. (2026) · Gastroenterology & Endoscopy · doi:10.1016/j.gande.2026.02.003 · Cited by 1
Grama, P., Ciorba, M., Popa, S., Ismaiel, A., & Bataga, S. M. (2026) · Metabolites · doi:10.3390/metabo16080536 · Cited by 1
“In the absence of IBD-specific data, weight-loss outcomes must be drawn from the general obesity literature and treated as indirect evidence; the figures for each modality are summarised in Table 1 and discussed in Section 4 [11,14,39].”
InfluentialIndex Endoscopic Bariatric and Metabolic Therapies
Rwigema, J.-C. N., Joseph, S., & Ujiki, M. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-72309-4_18
Primary endoscopic interventions in bariatric surgery
Nwaiwu, C. A., Hunte, E. M., Giorgi, M., & Pryor, A. D. (2025) · Mini-invasive Surgery · doi:10.20517/2574-1225.2024.112 · Cited by 1
Obesity and musculoskeletal pain: possibilities of pharmacotherapy. A narrative overview
Karateev, A. E., & Zotkin, E. G. (2025) · Russian Journal of Pain · doi:10.17116/pain20252303173
Propuesta de 100 recomendaciones de «no hacer» en la atención clínica de las personas con obesidad
Lesmes, I. B., Arnáiz, E. G., & Murillo, A. Z. (2026) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2025.102639
Yu, Q., Sun, J., Yang, Y., Zhu, W., & Ma, Y. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08489-5
FROM LIFESTYLE INTERVENTIONS TO BARIATRIC SURGERY: AN OVERVIEW OF OBESITY TREATMENT MODALITIES
Jamroch, K., Marek, A., Garncarz, K., Dziki, K., Dybizbańska, W., Nowakowska, Z., Burzej, A., Kacalak, M., Komenda, M., & Szklarska-Komenda, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4420
Depression Associated with Other Medical Conditions
Sunzeri, F., & Sunzeri, E. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_12
Martínez, R. M., Alarcón-Vela, A. L., & Espín, D. S. I. (2026) · Universidad Médica Pinareña
Metadata
- Authors
- Qureshi, H., Saeed, N., & Jovani, M.
- Affiliations
- University of Kentucky (US)
- Maimonides Medical Center (US)
- Corresponding author
- Jovani, Manol
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2023-01-31
- Volume
- 12
- Issue
- 3
- Pages
- 1126
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9917553
- OpenAlex
- W4319795290
- Cited by
- 21
- References
- 64
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 2 · 2023: 4
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- endoscopic bariatric therapy, obesity, weight loss, metabolic parameters, long-term outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.